U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601087) titled 'A Clinical Study of HRS-7156 in Healthy Participants' on May 15.
Brief Summary: The purpose of this Phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-7156 in healthy participants.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Intervention:
DRUG: HRS-7156
HRS-7156, specified dose on specified day.
DRUG: HRS-7156 placebo
HRS-7156 placebo, specified dose on specified day.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....